The recent financial crisis had a strong impact on the worldwide economy, particularly the crisis of 2007 known as the Global Financial Crisis GFC. What started as a US financial market crash resulted in a truly global crisis, impacting both financial and non-financial sectors. One of the markets involved was the derivatives market. As a result, both regulators and regulated firms are aware of the risks and uncertainties manufactured in the derivatives market, in particular in the OTCDM. In order to understand the role of risk and risk-based regulation in the context of the OTCDM and CCPs regime, this paper explores the rationale of derivatives as tools of distribution of risks. Following the notion of ‘manufactured risks’ of the risk society theory, it explains in detail why the OTCDM is a centre of production of risks. It also considers the post-GFC regulatory reforms and the move towards the use of CCPs. It puts forward the argument that the inclusion of CCPs in the OTCDM and the increase in mandatory central clearing adds complexity to the market, and thereby might become a source of new ‘manufactured risks’. This paper provides the framework of the OTC derivatives market. It is devoted to explain the physiology of Financial Derivatives. To this end, the work is divided into two parts. The first part addresses the fundamental questions of how financial derivatives work, with a critical overview of the uses of these transactions, and the traditional process of trading. Then, it highlights the differences between the exchange and the over-the-counter (OTC) markets, and how the post-crisis regulatory reforms have modified the structure and functioning of the OTCDM. Since the focus of this research is the OTCDM, the second part addresses the questions regarding the role that the OTC derivatives market played in the Global Financial Crisis, and the market failures that motivated current changes for more formal regulation and supervision. Such post-crisis regulatory reforms frame the object of study of this research, which is the major transformation of regulation and supervision of the OTC derivatives in the United Kingdom - as the biggest market of the world - and the consequent move towards the regulation of Central Counterparties CCPs, as new intermediaries of the market. The discussion of this paper concerning the decision to regulate CCPs in the OTCDM, as a means to enhance the stability of the market, is central to the analysis of this research. The aim is to explain the decision of UK regulators to regulate CCPs as a means of identifying, assessing and controlling the risks of the OTCDM collectively. This is instead of supervising individual firms that raise high risks.
Read full abstract